Market Currents
Johnson & Johnson (JNJ +0.4%) receives a favorable Barron's write-up. The paper talks up...
-
Friday, June 22, 2012, 1:55 PM ETJohnson & Johnson (JNJ +0.4%) receives a favorable Barron's write-up. The paper talks up J&J's 3.7% dividend yield, low P/E, diverse product line, and new drug launches, along with its recently-closed acquisition of medical device maker Synthes. (earlier)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
